Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
The largest consensus on the preferability of proton over photon radiation therapy is in paediatric oncology. Counting 70-80% survival rates, finding solutions that positively impact quality of life outcomes has become a growing focal point among paediatric oncologists.
Proton beams’ physical and biological properties support an advantageous quality of dose distribution, resulting in improved therapeutic gains. The clinical interest lies in the comparative impact of proton beam therapy versus alternatives such as photon beam treatment, either as a curative solution or salvage remedy for cancerous and noncancerous conditions and their effect on survival, disease progression, safety, health-related quality of life and other patient outcomes. An increasing emphasis on evidence-based medicine makes it worthwhile to assess the available data that supports proton therapy over other techniques to better guide the physician and patient toward the most appropriate treatment.
This white paper presents clinical outcomes data that proton therapy provides an effective means to achieve this end.
IBA White Paper
*Please refer to the Terms and Conditions of this website when leaving the site and viewing third party content.